Restricted accessOtherFirst published online 2007-12
Risk factors for progression of peripheral arterial disease in large and small vessels. Aboyans V,Criqui MH,Denenberg JO,Knoke JD,Ridker PM,Fronek A. Circulation. 2006;113:2623-2629
Tzoulaki I., Murray GD, Price JF, et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol . 2006;163:334-341.
2.
Musicant SE, Taylor LM Jr, Peters D., et al. Prospective evaluation of the relationship between C-reactive protein, D-dimer, and progression of peripheral arterial disease. J Vasc Surg.2006;43:772-780.
3.
Tap RJ, Balkau B., Shaw JE, Valensi P., Cailleau M., Eschwege E.Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study. Atherosclerosis. 2007;190:84-89.
4.
Taylor LM Jr, Moneta GL, Sexton GJ, Schuff RA, Porter JMProspective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg. 1999;29:8-19.
5.
Engström G., Site-Flondell D., Lindblad B., Janzon L., Lindgärde F.Risk of treatment of peripheral arterial disease is related to inflammation-sensitive proteins: a prospective cohort study. J Vasc Surg. 2004;40:1101-1105.
